NDC 43353-121

Lisinopril

Lisinopril

Lisinopril is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, Llc. The primary component is Lisinopril.

Product ID43353-121_c5c4e65e-ba37-4215-ba30-9b7a3d66f27e
NDC43353-121
Product TypeHuman Prescription Drug
Proprietary NameLisinopril
Generic NameLisinopril
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-01-07
Marketing CategoryANDA / ANDA
Application NumberANDA076071
Labeler NameAphena Pharma Solutions - Tennessee, LLC
Substance NameLISINOPRIL
Active Ingredient Strength20 mg/1
Pharm ClassesAngiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 43353-121-45

45 TABLET in 1 BOTTLE, PLASTIC (43353-121-45)
Marketing Start Date2016-11-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 43353-121-60 [43353012160]

Lisinopril TABLET
Marketing CategoryANDA
Application NumberANDA076071
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-04-19
Marketing End Date2019-08-31

NDC 43353-121-30 [43353012130]

Lisinopril TABLET
Marketing CategoryANDA
Application NumberANDA076071
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-11-08
Marketing End Date2019-08-31

NDC 43353-121-45 [43353012145]

Lisinopril TABLET
Marketing CategoryANDA
Application NumberANDA076071
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-11-18
Marketing End Date2019-08-31

NDC 43353-121-80 [43353012180]

Lisinopril TABLET
Marketing CategoryANDA
Application NumberANDA076071
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-04-23
Marketing End Date2019-08-31

Drug Details

Active Ingredients

IngredientStrength
LISINOPRIL20 mg/1

OpenFDA Data

SPL SET ID:03224534-6747-4053-8bb4-3d6dbc04f8cd
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 314077
  • 197884
  • 311353
  • 311354
  • 314076

    • Pharmacological Class

    • Angiotensin Converting Enzyme Inhibitor [EPC]
    • Angiotensin-converting Enzyme Inhibitors [MoA]

    NDC Crossover Matching brand name "Lisinopril" or generic name "Lisinopril"

    NDCBrand NameGeneric Name
    0143-1266LisinoprilLisinopril
    0143-1267LisinoprilLisinopril
    0143-1268LisinoprilLisinopril
    0143-1270LisinoprilLisinopril
    0143-9713LisinoprilLisinopril
    0143-9714LisinoprilLisinopril
    0143-9715LisinoprilLisinopril
    0185-0025lisinoprillisinopril
    0185-0101lisinoprillisinopril
    0185-0102lisinoprillisinopril
    0185-0103lisinoprillisinopril
    0185-0104lisinoprillisinopril
    0185-0602lisinoprillisinopril
    0185-0605lisinoprillisinopril
    0185-0610lisinoprillisinopril
    0185-0620lisinoprillisinopril
    0185-0630lisinoprillisinopril
    0185-0640lisinoprillisinopril
    0185-5400lisinoprillisinopril
    0378-2072Lisinoprillisinopril
    0378-2073Lisinoprillisinopril
    0378-2074Lisinoprillisinopril
    0378-2075Lisinoprillisinopril
    0378-2076Lisinoprillisinopril
    68001-270lisinoprillisinopril
    68001-271lisinoprillisinopril
    68001-267lisinoprillisinopril
    68001-272lisinoprillisinopril
    68001-334LisinoprilLisinopril
    68001-268lisinoprillisinopril
    68001-333LisinoprilLisinopril
    68001-335LisinoprilLisinopril
    68001-337LisinoprilLisinopril
    68001-269lisinoprillisinopril
    68001-336LisinoprilLisinopril
    68001-332LisinoprilLisinopril
    68071-1672LISINOPRILLISINOPRIL
    68071-1775LISINOPRILLISINOPRIL
    68071-3064LISINOPRILLISINOPRIL
    68071-1894LISINOPRILLISINOPRIL
    68071-3220LISINOPRILLISINOPRIL
    68071-3113LISINOPRILLISINOPRIL
    68071-3122LISINOPRILLISINOPRIL
    68071-1931LisinoprilLisinopril
    68071-3070lisinoprillisinopril
    68071-3043LISINOPRILLISINOPRIL
    68071-3123LISINOPRILLISINOPRIL
    68071-3145LISINOPRILLISINOPRIL
    68071-3178LISINOPRILLISINOPRIL
    68071-4660LisinoprilLisinopril
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.